Displaying drugs 7076 - 7100 of 7757 in total
CBP-501
Investigational
Matched Iupac: … carbamimidamidopentanamido]-4-carbamoylbutanamido]-5-carbamimidamidopentanamido]-5-carbamimidamidopentanoic acid …
PLX-4720
Experimental
T-900607
T900607 has been used in trials studying the treatment of Liver Cancer and Gastric Cancer.
Investigational
Cilnidipine
Cilnidipine is a dihydropyridine calcium antagonist. It was jointly developed by Fuji Viscera Pharmaceutical Company, Japan and Ajinomoto, Japan and approved in 1995. Compared with other calcium antagonists, cilnidipine can act on the N-type calcium channel that existing sympathetic nerve end besides acting on L-type calcium channel that similar to...
Investigational
Glufosfamide
Investigational
(2E)-3-(2,4-DICHLOROPHENYL)-N-HYDROXYACRYLAMIDE
Experimental
5-(2-methylpiperazine-1-sulfonyl)isoquinoline
Experimental
[Methylseleno]Acetate
Experimental
N-(2-Thienylmethyl)-2,5-Thiophenedisulfonamide
Experimental
1,2,5-THIADIAZOLIDIN-3-ONE-1,1-DIOXIDE
Experimental
PG-701
Hydroxytriptolide has been investigated for the treatment of Rheumatoid Arthritis.
Investigational
Salvinorin A
Salvinorin A has been investigated for the basic science of Pharmaceutical Preparations.
Investigational
Clodantoin
Experimental
Deacetoxyvinzolidine
Experimental
Nicotinamide adenine dinucleotide cyclohexanone
Experimental
Navitoclax
Navitoclax has been used in trials studying the treatment and basic science of Solid Tumors, Non-Hodgkin's Lymphoma, EGFR Activating Mutation, Chronic Lymphoid Leukemia, and Hematological Malignancies, among others.
Navitoclax is an orally bioavailable small molecule inhibitor of Bcl-2 family proteins. It is a substance being studied in the treatment of...
Investigational
Laromustine
VNP40101M is a novel alkylating agent that has been used in trials studying the treatment of Leukemia, Lymphoma, Lung Cancer, Small Intestine Cancer, and Myelodysplastic Syndromes, among others.
Investigational
Brefeldin A
A metabolite from Penicillium brefeldianum that exhibits a wide range of antibiotic activity.
Experimental
Ethoxzolamide
Ethoxzolamide is a sulfonamide used as diuretic and in glaucoma. It inhibits carbonic anhydrase activity in proximal renal tubules to decrease reabsorption of water, sodium, potassium, bicarbonate. Its pharmacological activity thus confers the risk for hypokalemia.
Withdrawn
Displaying drugs 7076 - 7100 of 7757 in total